0001209191-20-046342.txt : 20200812 0001209191-20-046342.hdr.sgml : 20200812 20200812161022 ACCESSION NUMBER: 0001209191-20-046342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200810 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ho Robert CENTRAL INDEX KEY: 0001806254 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 201095569 MAIL ADDRESS: STREET 1: 360-1616 EASTLAKE AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neoleukin Therapeutics, Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-732-2133 MAIL ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-10 0 0001404644 Neoleukin Therapeutics, Inc. NLTX 0001806254 Ho Robert C/O NEOLEUKIN THERAPEUTICS, INC. 360-1616 EASTLAKE AVENUE E. SEATTLE WA 98102 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 12.00 2020-08-10 4 A 0 90000 0.00 A 2030-08-10 Common Stock 90000 90000 D The option vests as to 1/4 of the total shares on August 10, 2021, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Robert Ho 2020-08-12